# DIBBS #SPE2DP-26-T-5250

DLA Solicitation for Docusate Sodium Capsules, USP, 100 mg (2 Bottles)

**Posted:** September 28, 2026
**Respond By:** October 05, 2026
**Identifier:** SPE2DP-26-T-5250
**NAICS:** 424210

This opportunity is issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA for Docusate Sodium Capsules.
- Government Buyer:
  - Defense Logistics Agency (DLA)
  - Troop Support Medical Supply Chain Pharmacy FSA
  - Buyer: Patrell Postell
- OEMs and Vendors:
  - GERI-CARE PHARMACEUTICALS CORP. (part number NDC57896-0401-25)
  - ATLANTIS CONSUMER HEALTHCARE INC. (part number NDC67618-0101-52)
- Products Requested:
  - Docusate Sodium Capsules, USP, 100 mg, bottles of 250 capsules
  - National Stock Number (NSN): 6505-00-582-5282
  - Quantity: 2 bottles
  - Approved sources: GERI-CARE PHARMACEUTICALS CORP. and ATLANTIS CONSUMER HEALTHCARE INC.
- Notable Requirements:
  - Delivery required within 20 days to Fort Bragg, NC
  - Compliance with Buy American Act and Berry Amendment
  - Hazardous material labeling and DLA packaging standards
  - Fast Award solicitation
- No additional technical requirements beyond approved sources and compliance standards.

### Description

DOCUSATE SODIUM CAPSUL (QTY: 2, NSN: 6505-00-582-5282, Purchase Request: 7018501982)
  Approved Sources:
  - CAGE: 06WD3, Part No: NDC57896-0401-25, Company: GERI-CARE PHARMACEUTICALS CORP.
  - CAGE: 9L4E0, Part No: NDC67618-0101-52, Company: ATLANTIS CONSUMER HEALTHCARE INC.
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DP26T5250)